Only half of patients take their medications as prescribed: are there interventions that will help them?
Strictly Embargoed Until 00.01 Hours (GMT), Thursday, November 20, 2014
Evelyn Martinez (US): +1 201 748 6358
Jo Anthony (UK): +44 (0) 1865 310138 or +44 (0) 7990 031904
Three Cochrane Review Groups - Pain, Palliative and Supportive Care (PaPaS), Musculoskeletal (MSG) and Neuromuscular Diseases (NMD) - are planning to hold an hour-long Tweetchat on patient-preferred fibromyalgia outcomes on Tuesday 9th December, at 13:00 GMT, using the hashtag #CCFibro.
For more information, see below:
Objective: for Cochrane Review Groups to engage with relevant consumer and patient groups using simple questions to identify important outcomes in fibromyalgia, via Twitter.Contributor's Information Contributor's name: Anna Hobson Email address: email@example.com
The Canadian Cochrane Centre (CCC) is pleased to announce the winners of its 'What's your story?' competition, highlighting stories of how Cochrane evidence has made an impact on the lives of Canadians.External link for more information: http://ccnc.cochrane.org/winners-whats-your-story-compe... Contributor's Information Contributor's name: Lori Tarbett Email address: firstname.lastname@example.org
A new survey about prioritising research questions in mild to moderate hearing loss has been launched by the James Lind Alliance (JLA), with the support of UK-based Cochrane contributors. The JLA has set up a Priority Setting Partnership (PSP) to identify unanswered questions for mild-moderate hearing loss; its causes, diagnosis, management and self-management.External link for more information: http://www.hearinglink.org/jla-psp/survey Contributor's Information Contributor's name: Sarah Chapman Email address: Sarah.Chapman@cochrane.nhs.uk
Cochrane Depression, Anxiety and Neurosis Group announces the establishment of a Suicide and Self-Harm Satellite
It is with great pleasure that the Cochrane Depression, Anxiety and Neurosis Group (CCDAN) announces the formation of a Suicide and Self-Harm satellite based in Swansea, Wales.External link for more information: http://ccdan.cochrane.org/ Contributor's Information Contributor's name: Jessica Sharp Email address: email@example.com
Strictly Embargoed Until 00.01 Hours (GMT), Thursday, November 6, 2014
[19.01 Hours US Eastern Time, Wednesday, November 5 /11.01 Hours Australian Eastern Daylight Time (AEDT), November 6]
Please take some time to fill out the evaluation forms for the 22nd Cochrane Colloquium using the link provided below.
If you were a day registrant, you can give your feedback just for that particular day.External link for more information: https://colloquium.cochrane.org/22nd-cochrane-colloquiu... Contributor's Information Contributor's name: Anna Joseph Email address: firstname.lastname@example.org
The first ever citation screening challenge is complete!
Starting at 15:00 GMT on Friday 31st October and running for 48 hours, around 75 EMBASE project screeners worked their way through 20,709 citations, in the process identifying 1713 RCTs. To put this into context, this work, completed in two days, is about the same amount of records as screeners typically review in two months.External link for more information: http://www.metaxis.com/EmbaseChallenge Contributor's Information Contributor's name: Anna Noel-Storr Email address: email@example.com
Strictly Embargoed Until 00.01 Hours (GMT), Thursday, October 30, 2014
[20.01 Hours US Eastern Time (EDT), October 29 /11.01 Hours Australian Eastern Daylight Time (AEDT), October 30]
It seems to me that what is missing is the views of parents and partners of patients who can give their take on what the patients are reporting. Only then will the true picture of the situation of people with psychosis be available, as patient views would be ratified - or contradicted - by those involved in their care long-term.
Our son started experimenting with cannabis when he was fourteen and we feel strongly that this contributed to his developing schizophrenia from about the age of seventeen. It became apparent during his prolonged stay in a psychiatric unit under a section that he was also treatment resistant. Only when he was treated with clozapine which had to be augmented did he begin to stabilise.
The doctor treating him felt that he, in his practice, was seeing more young men like this and he felt that the brain being bathed in these illicit drugs during adolescence was a contributory factor.
Our son managed to procure cannabis whilst in hospital under section and was cautioned and fined for this despite at the time not being deemed fit to make decisions. Fortunately he now no longer smokes cannabis but has to take medication and lives in supported accommodation. He is now 23 years old and is just beginning to have a life again.
I believe that all mind altering drugs are harmful. The ideal psychiatric system would be Open Dialogue, a non-invasive method with a very minimal use of drugs. ANY mind altering drug is just a short cut, panic measure, which might work for a short time, but with unpredictable and often very disastrous long-term effects.
Schizophrenia is a serious mental illness and is usually treated using antipsychotic medication. However, although effective, antipsychotic medication can cause side-effects (such as sleepiness, weight gain and even dribbling). Acupuncture has been shown to have very few negative effects on the individual and could be more socially acceptable and tolerable for people with mental health problems. Acupuncture may also be less expensive than drugs made by pharmaceutical companies, so reducing costs to individuals and health services.
This reviews looks at the effectiveness of various types of acupuncture as treatment for people with schizophrenia. An update search for studies was carried out in 2012 and found 30 studies that randomised participants who were receiving antipsychotic medication to receive additional acupuncture or standard care.
Although some of the studies did favour acupuncture when combined with antipsychotics, the information available was small scale and rated to be very low or low quality by the review authors, so not completely provable and valid. Depression was reduced when combining acupuncture with antipsychotic medication, but again this finding came from small-scale research, so cannot be clearly shown to be true. The review concludes that people with mental health problems, policy makers and health professionals need much better evidence in order to establish if there are any potential benefits to acupuncture.
This means that the question of whether acupuncture is of benefit to people, and whether it is of greater benefit than antipsychotic medication, remains unanswered. There is not enough information to establish that acupuncture is of benefit or harm to people with mental health problems.
See more at: http://summaries.cochrane.org/CD005475/SCHIZ_acupuncture-for-schizophrenia